Exact Mass: 413.11

Exact Mass Matches: 413.11

Found 224 metabolites which its exact mass value is equals to given mass value 413.11, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

(-)-alpha-Narcotine

(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-one

C22H23NO7 (413.1474)


(-)-alpha-Narcotine is found in opium poppy. (-)-alpha-Narcotine is an alkaloid from Papaver somniferum (opium poppy).Noscapine (also known as Narcotine, Nectodon, Nospen, and Anarcotine) is a benzylisoquinoline alkaloid from plants of the Papaveraceae family, without significant painkilling properties. This agent is primarily used for its antitussive (cough-suppressing) effects. It has also been shown to have anticancer activity. (Wikipedia). R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents Alkaloid from Papaver somniferum (opium poppy) D002491 - Central Nervous System Agents

   

Aminodeoxyfutalosine

6-Amino-6-deoxyfutalosine

C19H19N5O6 (413.1335)


   

13E-Tetranor-16-carboxy-LTE4

(3E,5Z,7E,9E,11R,12S)-11-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid

C19H27NO7S (413.1508)


13E-tetranor-16-carboxy-LTE4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 13E-tetranor-16-carboxy-LTE4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)

   

(±)-alpha-Narcotine

6,7-dimethoxy-3-{4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one

C22H23NO7 (413.1474)


(±)-alpha-Narcotine is formed in opium, as an artifact. Formed in opium, prob. as an artifact

   

4-(2-Hydroxy-3-(tert-butylamino)propoxy)-3-iodo-1H-indole-2-carbonitrile

4-(2-Hydroxy-3-(tert-butylamino)propoxy)-3-iodo-1H-indole-2-carbonitrile

C16H20IN3O2 (413.06)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Piperazine, 1-((1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methyl-

Piperazine, 1-((1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methyl-

C23H25Cl2N3 (413.1425)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

   

5-{2-Fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid

5-(2-fluoro-5-{3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]prop-1-en-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid

C21H16FNO7 (413.0911)


   

EGFR Inhibitor

N-{3-[(6-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}cyclopropanecarboxamide

C21H18F3N5O (413.1463)


   

Fosdevirine

5-Chloro-3-{[3-(2-cyanoeth-1-en-1-yl)-5-methylphenyl](methoxy)phosphoroso}-1H-indole-2-carboximidate

C20H17ClN3O3P (413.0696)


   

Glucose lactate glutamate

2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl 4-amino-5-[(2-hydroxypropanoyl)peroxy]-5-oxopentanoic acid

C14H23NO13 (413.1169)


   

1-Piperazinecarboxylic acid, 4-((3,4-dichlorophenyl)acetyl)-3-(1-pyrrolidinylmethyl)-, methyl ester, (3R)-

1-Piperazinecarboxylic acid, 4-((3,4-dichlorophenyl)acetyl)-3-(1-pyrrolidinylmethyl)-, methyl ester, (3R)-

C19H25Cl2N3O3 (413.1273)


   

3beta-(4-Iodophenyl)tropan-2beta-carboxylic acid isopropyl ester

3-(4-Iodo-phenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid isopropyl ester

C18H24INO2 (413.0852)


   
   
   
   

Oreonone

1-Methoxy-13-oxoallocryptopine

C22H23NO7 (413.1474)


   
   
   
   
   

2-methyl-3-hydroxybutanenitrile beta-D-glucopyranoside 6-O-gallate|supinanitriloside D

2-methyl-3-hydroxybutanenitrile beta-D-glucopyranoside 6-O-gallate|supinanitriloside D

C18H23NO10 (413.1322)


   

Methyl anhydroberberillate

Methyl anhydroberberillate

C21H19NO8 (413.1111)


   

L-|A-Glutamyl-S-[(4-hydroxyphenyl)methyl]-L-cysteinylglycine

L-|A-Glutamyl-S-[(4-hydroxyphenyl)methyl]-L-cysteinylglycine

C17H23N3O7S (413.1257)


   

(R)-2-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6-O-gallate|(R)-lotaustralin 6-O-gallate|supinanitriloside C

(R)-2-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6-O-gallate|(R)-lotaustralin 6-O-gallate|supinanitriloside C

C18H23NO10 (413.1322)


   
   

rhodochelin tripeptide

rhodochelin tripeptide

C17H23N3O9 (413.1434)


   

UNII-6KQ3QJ08FF

UNII-6KQ3QJ08FF

C23H19N5O3 (413.1488)


   
   

2-hydroxymethylbutanenitrile beta-D-glucopyranoside 6-O-gallate|supinanitriloside A 6-O-gallate|supinanitriloside B

2-hydroxymethylbutanenitrile beta-D-glucopyranoside 6-O-gallate|supinanitriloside A 6-O-gallate|supinanitriloside B

C18H23NO10 (413.1322)


   

narcotine

beta-Narcotine

C22H23NO7 (413.1474)


Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Morphine alkaloids

   
   

Bicucullinine

Bicucullinine

C21H19NO8 (413.1111)


   

5-p-hydroxycinnamoyl adenosine|amaricine

5-p-hydroxycinnamoyl adenosine|amaricine

C19H19N5O6 (413.1335)


   

beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-alanyl]glucopyranoside

beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-alanyl]glucopyranoside

C15H27NO12 (413.1533)


   

Aureonuclemycin

Aureonuclemycin

C15H19N5O9 (413.1183)


   

3-hydroxy-3-methylbutanenitrile beta-D-glucopyranoside 6-O-gallate|supinanitriloside E

3-hydroxy-3-methylbutanenitrile beta-D-glucopyranoside 6-O-gallate|supinanitriloside E

C18H23NO10 (413.1322)


   
   
   
   
   
   

S-(4-Hydroxybenzyl)glutathione

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(4-hydroxyphenyl)methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C17H23N3O7S (413.1257)


S-(4-Hydroxybenzyl)glutathione is a natural product found in Gastrodia elata with data available. S-(4-Hydroxybenzyl)glutathione is a glutathione derivative. S-(4-Hydroxybenzyl)glutathione inhibits the in vitro binding of kainic acid to brain glutamate receptors, with an IC50 of 2 μM[1].

   

Noscapine

(3S)-3-[(5R)-6-methyl-4-(methyloxy)-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-bis(methyloxy)-2-benzofuran-1(3H)-one

C22H23NO7 (413.1474)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.727 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.725 IPB_RECORD: 1361; CONFIDENCE confident structure CONFIDENCE standard compound; EAWAG_UCHEM_ID 3024

   

S,R-Noscapine

S,R-Noscapine

C22H23NO7 (413.1474)


Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2481; CONFIDENCE confident structure

   

6,7-dimethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-2-benzofuran-1-one

NCGC00015757-10!6,7-dimethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-2-benzofuran-1-one

C22H23NO7 (413.1474)


   
   

(S,R)-Nosapine

(S,R)-Nosapine

C22H23NO7 (413.1474)


   
   

Longatin

Noscapine

C22H23NO7 (413.1474)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Morphine alkaloids, Noscapine alkaloids D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

   
   
   
   
   
   
   
   

Ser-Trp-OH

(S)-2-(3-(2-hydroxyethoxy)-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C20H19N3O7 (413.1223)


   

Trp-Ser-OH

(S)-2-(3-(2-(1H-indol-3-yl)ethoxy)-4-nitrobenzamido)-4-hydroxybutanoic acid

C20H19N3O7 (413.1223)


   

Gnoscopine

6,7-dimethoxy-3-{4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one

C22H23NO7 (413.1474)


   

16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4

(5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid

C19H27NO7S (413.1508)


An icosanoid that is leukotriene E4 in which the isolated double bond has migrated into conjugation with the triene moiety and in which four methylene groups have been lost from the resulting carboxyalkyl chain.

   

R306465

N-hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide

C19H19N5O4S (413.1158)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   
   

3-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(2-chlorophenothiazin-10-yl)propan-1-one

3-(3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-1-(2-chlorophenothiazin-10-yl)propan-1-one

C22H24ClN3OS (413.1329)


   

(Rp)-1-(1S)-[(2-Diphenylphosphino)ferrocenyl]ethanamine

(Rp)-1-(1S)-[(2-Diphenylphosphino)ferrocenyl]ethanamine

C24H24FeNP (413.0996)


   

[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl][4-(3-methy lphenyl)-1-piperazinyl]methanone

[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl][4-(3-methy lphenyl)-1-piperazinyl]methanone

C22H21ClFN3O2 (413.1306)


   

2-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-5-(phenylazo)thiophene-3-carbonitrile

2-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-5-(phenylazo)thiophene-3-carbonitrile

C22H19N7S (413.1423)


   
   

Z-Phe-Gly-Gly-OH

Z-Phe-Gly-Gly-OH

C21H23N3O6 (413.1587)


   

Obatoclax Mesylate

Obatoclax Mesylate

C21H23N3O4S (413.1409)


D004791 - Enzyme Inhibitors

   

(2-dimethylaminoethyl)triphenylphosphonium bromide

(2-dimethylaminoethyl)triphenylphosphonium bromide

C22H25BrNP (413.0908)


   

5-chloro-2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride

5-chloro-2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride

C23H25Cl2N3 (413.1425)


   
   

NU7441(KU-57788)

8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one

C25H19NO3S (413.1086)


   

CJ-42794

(S)-4-(1-(5-chloro-2-(4-fluorophenoxy)benzamido)ethyl)benzoic acid

C22H17ClFNO4 (413.083)


   

[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate

[7-(4-nitrooxybutoxy)-4-oxo-2-phenylchromen-5-yl] acetate

C21H19NO8 (413.1111)


   

FLUORESCENT YELLOW AA223

3-(5-(Aminosulfonyl)benzoxazol-2-yl)-7-(diethylamino)coumarin

C20H19N3O5S (413.1045)


   

Bretylium tosylate

Bretylium (tosylate)

C18H24BrNO3S (413.066)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Bretylium (tosylate) is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters. It is the sympathetic nerve and adrenergic ganglion blocking agent . (1) Bretylium tosylate inhibits adrenergic function presynaptically only after an initial release in neurotransmitter substance. (2) The reference for administration dose is 15 mg/kg (I.P).

   

Disperse Blue 148

Disperse Blue 148

C19H19N5O4S (413.1158)


   

1,3-Diethyl-2-thiobarbituricacid

1,3-Diethyl-2-thiobarbituricacid

C23H19N5O3 (413.1488)


   

Z-Gly-Gly-Phe-OH

Z-Gly-Gly-Phe-OH

C21H23N3O6 (413.1587)


   

1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1S,2S)-(+)-2-(dimethylamino)cyclohexyl]thiourea(S,S-TUC)

1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1S,2S)-(+)-2-(dimethylamino)cyclohexyl]thiourea(S,S-TUC)

C17H21F6N3S (413.136)


   

4-hydroxy-alpha-[[[3-(4-methoxyphenyl)-1-methylpropyl]amino]methyl]-3-(methylsulphinyl)benzyl alcohol hydrochloride

4-hydroxy-alpha-[[[3-(4-methoxyphenyl)-1-methylpropyl]amino]methyl]-3-(methylsulphinyl)benzyl alcohol hydrochloride

C20H28ClNO4S (413.1427)


   

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,2-cyanoguanidine,sulfuric acid,hydrochloride

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,2-cyanoguanidine,sulfuric acid,hydrochloride

C9H25Cl2N7O5S (413.1015)


   

1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1R,2R)-(-)-2-(dimethylamino)cyclohexyl]thiourea(R,R-TUC)

1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1R,2R)-(-)-2-(dimethylamino)cyclohexyl]thiourea(R,R-TUC)

C17H21F6N3S (413.136)


   
   

6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline hydrochloride

6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline hydrochloride

C19H14ClF2N7 (413.0967)


   

3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane bromide monohydrate

3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane bromide monohydrate

C20H32BrNO3 (413.1565)


   

10-Methyl-9-(phenoxycarbonyl)acridinium fluorosulfonate

10-Methyl-9-(phenoxycarbonyl)acridinium fluorosulfonate

C21H16FNO5S (413.0733)


   

(4-cyanobenzyl)triphenylphosphonium chloride

(4-cyanobenzyl)triphenylphosphonium chloride

C26H21ClNP (413.11)


   

Aurora Kinase Inhibitor III

Aurora Kinase Inhibitor III

C21H18F3N5O (413.1463)


   

Fosdevirine

Unii-Z4I0C281BJ

C20H17ClN3O3P (413.0696)


C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

   

Narcotine, (+)-

Narcotine, (+)-

C22H23NO7 (413.1474)


   

2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone

2-(2,6-dichlorobenzyl)-6-phenyl-5-piperidino-3(2H)-pyridazinone

C22H21Cl2N3O (413.1062)


   

4-Methyl-3-nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

4-Methyl-3-nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

C19H15N3O6S (413.0682)


   

4-[benzyl(propan-2-yl)sulfamoyl]-N-(5-methyl-1,2-oxazol-3-yl)benzamide

4-[benzyl(propan-2-yl)sulfamoyl]-N-(5-methyl-1,2-oxazol-3-yl)benzamide

C21H23N3O4S (413.1409)


   

5-{2-Fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid

5-{2-Fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid

C21H16FNO7 (413.0911)


   

3-Diphenol-6-nitro-3H-benzo[DE]isochromen-1-one

3-Diphenol-6-nitro-3H-benzo[DE]isochromen-1-one

C24H15NO6 (413.0899)


   

4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

4-({4-[(4-Aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

C17H23N3O5S2 (413.1079)


   

(3r)-3-Cyclopentyl-7-[(4-Methylpiperazin-1-Yl)sulfonyl]-3,4-Dihydro-2h-1,2-Benzothiazine 1,1-Dioxide

(3r)-3-Cyclopentyl-7-[(4-Methylpiperazin-1-Yl)sulfonyl]-3,4-Dihydro-2h-1,2-Benzothiazine 1,1-Dioxide

C18H27N3O4S2 (413.1443)


   

Delta(13)-16-carboxy-tetranor-LTE4

Delta(13)-16-carboxy-tetranor-LTE4

C19H27NO7S (413.1508)


   

N(6)-(dimethylallyl)adenosine 5-phosphate(2-)

N(6)-(dimethylallyl)adenosine 5-phosphate(2-)

C15H20N5O7P-2 (413.11)


   
   

15-Demethoxy-epsilon-rhodomycinone

15-Demethoxy-epsilon-rhodomycinone

C21H17O9- (413.0873)


   

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 4-amino-5-(2-hydroxypropanoylperoxy)-5-oxopentanoate

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] 4-amino-5-(2-hydroxypropanoylperoxy)-5-oxopentanoate

C14H23NO13 (413.1169)


   

6-[[(2-Ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

6-[[(2-Ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C21H21N2O5S- (413.1171)


   

(+)-Malbrancheamide C

(+)-Malbrancheamide C

C21H24BrN3O (413.1103)


   

acs.jmedchem.1c00409_ST.481

acs.jmedchem.1c00409_ST.481

C23H15N3O5 (413.1012)


   

5-[(1,3-Benzodioxol-5-ylmethylamino)methylidene]-1-[(4-fluorophenyl)methyl]-2-sulfanylidene-1,3-diazinane-4,6-dione

5-[(1,3-Benzodioxol-5-ylmethylamino)methylidene]-1-[(4-fluorophenyl)methyl]-2-sulfanylidene-1,3-diazinane-4,6-dione

C20H16FN3O4S (413.0846)


   

3-Methyl-2-benzofurancarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester

3-Methyl-2-benzofurancarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester

C21H23N3O6 (413.1587)


   

2-[5-(4-hydroxy-3-nitrobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(3-methylphenyl)acetamide

2-[5-(4-hydroxy-3-nitrobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]-N-(3-methylphenyl)acetamide

C19H15N3O6S (413.0682)


   

N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

N-(4-acetylphenyl)-2-[[1-(3,5-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

C19H19N5O4S (413.1158)


   

(+)-Isomalbrancheamide C

(+)-Isomalbrancheamide C

C21H24BrN3O (413.1103)


   

N-[4-(1-adamantyl)-2-thiazolyl]-N-[(4-fluorophenyl)methyl]oxamide

N-[4-(1-adamantyl)-2-thiazolyl]-N-[(4-fluorophenyl)methyl]oxamide

C22H24FN3O2S (413.1573)


   

9,10-Dioxo-1-anthracenecarboxylic acid [2-(2,3-dimethylanilino)-2-oxoethyl] ester

9,10-Dioxo-1-anthracenecarboxylic acid [2-(2,3-dimethylanilino)-2-oxoethyl] ester

C25H19NO5 (413.1263)


   

4-hydroxy-N-[[2-oxo-1-(3-oxo-1H-isobenzofuran-1-yl)-3-indolylidene]amino]benzamide

4-hydroxy-N-[[2-oxo-1-(3-oxo-1H-isobenzofuran-1-yl)-3-indolylidene]amino]benzamide

C23H15N3O5 (413.1012)


   

2-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]sulfanyl-3-ethyl-5,6-dimethylthieno[2,3-d]pyrimidin-4-one

2-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]sulfanyl-3-ethyl-5,6-dimethylthieno[2,3-d]pyrimidin-4-one

C21H23N3O2S2 (413.1232)


   

6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one

6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one

C22H23NO7 (413.1474)


   

2-[1-[[4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5,6-dimethyl-3H-thieno[2,3-d]pyrimidin-4-one

2-[1-[[4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5,6-dimethyl-3H-thieno[2,3-d]pyrimidin-4-one

C19H19N5O2S2 (413.098)


   

3-(2,5-dioxo-1-pyrrolidinyl)-N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide

3-(2,5-dioxo-1-pyrrolidinyl)-N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide

C24H19N3O4 (413.1375)


   

6-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-3,4-dihydro-1H-quinolin-2-one

6-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-3,4-dihydro-1H-quinolin-2-one

C21H23N3O4S (413.1409)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]acetamide

N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]acetamide

C21H23N3O4S (413.1409)


   

4-[[(5-Methyl-3-isoxazolyl)amino]methylidene]-2-[3-(trifluoromethyl)phenyl]isoquinoline-1,3-dione

4-[[(5-Methyl-3-isoxazolyl)amino]methylidene]-2-[3-(trifluoromethyl)phenyl]isoquinoline-1,3-dione

C21H14F3N3O3 (413.0987)


   

6-Cyano-1-(2-methylphenyl)-7-(4-methylphenyl)-5-oxo-[1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylic acid ethyl ester

6-Cyano-1-(2-methylphenyl)-7-(4-methylphenyl)-5-oxo-[1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylic acid ethyl ester

C23H19N5O3 (413.1488)


   

N-(2-{6-[(2-Hydroxy-benzoyl)-hydrazonomethyl]-7-methoxy-benzo[1,3]dioxol-5-yl}-ethyl)-N-methyl-acetamide

N-(2-{6-[(2-Hydroxy-benzoyl)-hydrazonomethyl]-7-methoxy-benzo[1,3]dioxol-5-yl}-ethyl)-N-methyl-acetamide

C21H23N3O6 (413.1587)


   

(3S)-6,7-dimethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one

(3S)-6,7-dimethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one

C22H23NO7 (413.1474)


   

N-(1,3-benzodioxol-5-ylmethyl)-6-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-quinazolinamine

N-(1,3-benzodioxol-5-ylmethyl)-6-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-quinazolinamine

C24H19N3O4 (413.1375)


   

4-[(2E)-2-[1-[4-(Furan-2-ylmethylsulfamoyl)phenyl]ethylidene]hydrazinyl]benzoic acid

4-[(2E)-2-[1-[4-(Furan-2-ylmethylsulfamoyl)phenyl]ethylidene]hydrazinyl]benzoic acid

C20H19N3O5S (413.1045)


   

3-Acetyl-4a,6,7,12a-tetrahydroxy-9-methoxy-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate

3-Acetyl-4a,6,7,12a-tetrahydroxy-9-methoxy-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate

C21H17O9- (413.0873)


   
   
   

methyl 1-(4-chlorophenyl)-5-[(E)-(phenylcarbamothioylhydrazinylidene)methyl]pyrazole-4-carboxylate

methyl 1-(4-chlorophenyl)-5-[(E)-(phenylcarbamothioylhydrazinylidene)methyl]pyrazole-4-carboxylate

C19H16ClN5O2S (413.0713)


   

(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

C25H23N3OS (413.1562)


   

4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C21H23N3O4S (413.1409)


   

4-[4-[(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C21H23N3O4S (413.1409)


   

(2R,3S,4R)-3-[4-(cyclopenten-1-yl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-1,3-thiazol-2-yl)azetidine-2-carbonitrile

(2R,3S,4R)-3-[4-(cyclopenten-1-yl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-1,3-thiazol-2-yl)azetidine-2-carbonitrile

C25H23N3OS (413.1562)


   

4-[4-[(2R,3S,4S)-2-cyano-4-(hydroxymethyl)-1-methylsulfonylazetidin-3-yl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2R,3S,4S)-2-cyano-4-(hydroxymethyl)-1-methylsulfonylazetidin-3-yl]phenyl]-N,N-dimethylbenzamide

C21H23N3O4S (413.1409)


   

(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

(2S,3R,4S)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

C25H23N3OS (413.1562)


   

(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

(2S,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

C25H23N3OS (413.1562)


   

4-[4-[(2R,3R,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2R,3R,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C21H23N3O4S (413.1409)


   

4-[4-[(2R,3S,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2R,3S,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C21H23N3O4S (413.1409)


   

4-[4-[(2S,3S,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2S,3S,4R)-2-cyano-4-(hydroxymethyl)-1-methylsulfonyl-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C21H23N3O4S (413.1409)


   

(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-1-(4-phenyl-2-thiazolyl)-2-azetidinecarbonitrile

C25H23N3OS (413.1562)


   
   
   
   
   
   
   
   
   

diaquabis(L-histidine)copper(2+)

diaquabis(L-histidine)copper(2+)

C12H26CuN6O6+4 (413.121)


   
   
   
   
   
   
   

2-Amino-3-[(2-hexanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

2-Amino-3-[(2-hexanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C15H28NO10P (413.1451)


   

2-Amino-3-[(3-butanoyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

2-Amino-3-[(3-butanoyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C15H28NO10P (413.1451)


   

3-[(3-Acetyloxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

3-[(3-Acetyloxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C15H28NO10P (413.1451)


   

methyl 4-[2-(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate

methyl 4-[2-(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate

C19H25Cl2N3O3 (413.1273)


   

4-(2-Hydroxy-3-(tert-butylamino)propoxy)-3-iodo-1H-indole-2-carbonitrile

4-(2-Hydroxy-3-(tert-butylamino)propoxy)-3-iodo-1H-indole-2-carbonitrile

C16H20IN3O2 (413.06)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

beta-Narcotine

beta-Narcotine

C22H23NO7 (413.1474)


   
   

(13E)-16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4

(13E)-16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4

C19H27NO7S (413.1508)


A 16-carboxy-Delta(13)-17,18,19,20-tetranor-leukotriene E4 in which the double bond at position 13-14 has E-configuration.

   

(-)-noscapine

(-)-noscapine

C22H23NO7 (413.1474)


A benzylisoquinoline alkaloid that is 1,2,3,4-tetrahydroisoquinoline which is substituted by a 4,5-dimethoxy-3-oxo-1,3-dihydro-2-benzofuran-1-yl group at position 1, a methylenedioxy group at positions 6-7 and a methoxy group at position 8. Obtained from plants of the Papaveraceae family, it lacks significant painkilling properties and is primarily used for its antitussive (cough-suppressing) effects.

   

TAN-1612(1-)

TAN-1612(1-)

C21H17O9 (413.0873)


An enolate resulting from the deprotonation of the hydroxy group of the enol moiety of TAN-1612.

   
   
   
   
   

(Rac)-NMDAR antagonist 1

(Rac)-NMDAR antagonist 1

C20H20BrN3O2 (413.0739)


(Rac)-NMDAR antagonist 1 is the racemate of NMDAR antagonist 1. NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist[1].

   

CBiPES (hydrochloride)

CBiPES (hydrochloride)

C21H20ClN3O2S (413.0965)


CBiPES hydrochloride is a mGlu2 receptor positive allosteric modulator (EC50: 92.8 nM). CBiPES hydrochloride attenuates stress-induced hyperthermia and PCP-induced hyperlocomotor activity. CBiPES hydrochloride can be used for research of neurological disease[1][2].

   

HLI373 (dihydrochloride)

HLI373 (dihydrochloride)

C18H25Cl2N5O2 (413.1385)


HLI373 dihydrochloride is an efficacious Hdm2 inhibitor. HLI373 dihydrochloride inhibits the ubiquitin ligase activity of Hdm2. HLI373 dihydrochloride is effective in inducing apoptosis of several tumor cells that are sensitive to DNA-damaging agents[1]. Antimalarial activity[2].

   

LUF6096

LUF6096

C22H21Cl2N3O (413.1062)


LUF6096, a potent allosteric enhancer of the adenosine A3 receptor, is able to allosterically enhance agonist binding. LUF6096 shows low orthosteric affinity for any of the adenosine receptors. LUF6096 shows protective effects in myocardial ischemia/reperfusion injury[1][2].

   

(5s,8s,9r)-8-benzoyl-2-[(2s,3r)-3-[(1z)-but-1-en-1-yl]oxiran-2-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5s,8s,9r)-8-benzoyl-2-[(2s,3r)-3-[(1z)-but-1-en-1-yl]oxiran-2-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO7 (413.1474)


   

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H23N3O7S (413.1257)


   

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s)-2-aminopropanoate

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s)-2-aminopropanoate

C15H27NO12 (413.1533)


   

4-(4-hydroxyphenyl)-12-methyl-1,3-dioxo-2-oxa-7,12-diazatetraphene-8-carboximidic acid

4-(4-hydroxyphenyl)-12-methyl-1,3-dioxo-2-oxa-7,12-diazatetraphene-8-carboximidic acid

C23H15N3O5 (413.1012)


   

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

C21H19NO8 (413.1111)


   

2-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(methoxymethyl)oxane-3,4,5-triol

2-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(methoxymethyl)oxane-3,4,5-triol

C16H23N5O8 (413.1547)


   

(s)-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8s)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

(s)-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8s)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

C17H23N3O9 (413.1434)


   

4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid

4,5,7-trihydroxy-n-(1-methoxy-3-methyl-1-oxobutan-2-yl)-9,10-dioxoanthracene-2-carboximidic acid

C21H19NO8 (413.1111)


   

[(2r,3s,4s,5r,6s)-6-[(1-cyano-2-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-6-[(1-cyano-2-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(4-hydroxyphenyl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H23N3O7S (413.1257)


   

{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}({2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl})acetic acid

{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}({2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl})acetic acid

C17H23N3O9 (413.1434)


   

(2s)-2-{[(2s,3s)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxybutylidene]amino}-5-(n-hydroxyformamido)pentanoic acid

(2s)-2-{[(2s,3s)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxybutylidene]amino}-5-(n-hydroxyformamido)pentanoic acid

C17H23N3O9 (413.1434)


   

[(2r,3s,4s,5r,6r)-6-(2-cyano-2-ethylethoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6r)-6-(2-cyano-2-ethylethoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid

4,5,7-trihydroxy-n-[(2s)-1-methoxy-3-methyl-1-oxobutan-2-yl]-9,10-dioxoanthracene-2-carboximidic acid

C21H19NO8 (413.1111)


   

5-{2-fluoro-5-[(1e)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]prop-1-en-1-yl]phenyl}-1,2-oxazole-3-carboxylic acid

5-{2-fluoro-5-[(1e)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]prop-1-en-1-yl]phenyl}-1,2-oxazole-3-carboxylic acid

C21H16FNO7 (413.0911)


   

(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

(2s,3s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylpentanoic acid

C21H19NO8 (413.1111)


   

{6-[(1-cyano-1-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3,4,5-trihydroxybenzoate

{6-[(1-cyano-1-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

C21H19NO8 (413.1111)


   

[6-(2-cyano-2-ethylethoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[6-(2-cyano-2-ethylethoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

(5r,8s,9r)-8-benzoyl-2-[(2s,3r)-3-[(1z)-but-1-en-1-yl]oxiran-2-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(2s,3r)-3-[(1z)-but-1-en-1-yl]oxiran-2-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO7 (413.1474)


   

n-[(9s)-5,13,19-trimethoxy-6-oxo-15,17-dioxatetracyclo[10.7.0.0²,⁸.0¹⁴,¹⁸]nonadeca-1(19),2,4,7,12,14(18)-hexaen-9-yl]ethanimidic acid

n-[(9s)-5,13,19-trimethoxy-6-oxo-15,17-dioxatetracyclo[10.7.0.0²,⁸.0¹⁴,¹⁸]nonadeca-1(19),2,4,7,12,14(18)-hexaen-9-yl]ethanimidic acid

C22H23NO7 (413.1474)


   

8-benzoyl-2-{3-[(1e)-but-1-en-1-yl]oxiran-2-yl}-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-{3-[(1e)-but-1-en-1-yl]oxiran-2-yl}-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO7 (413.1474)


   

[(2r,3s,4s,5r,6r)-6-[(2s)-2-cyano-2-ethylethoxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6r)-6-[(2s)-2-cyano-2-ethylethoxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

{6-[(1-cyano-2-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3,4,5-trihydroxybenzoate

{6-[(1-cyano-2-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

[6-(1-cyano-1-methylpropoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[6-(1-cyano-1-methylpropoxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

2-(4-fluorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

2-(4-fluorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20FNO3 (413.1427)


   

{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8r)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8r)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

C17H23N3O9 (413.1434)


   

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-aminopropanoate

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-aminopropanoate

C15H27NO12 (413.1533)


   

[(2r,3s,4s,5r,6r)-6-[(1-cyano-1-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6r)-6-[(1-cyano-1-methylpropan-2-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

2-(3-fluorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

2-(3-fluorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20FNO3 (413.1427)


   

(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-7-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H24BrN3O (413.1103)


   

(2s,3r,4s,5s,6r)-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(methoxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(methoxymethyl)oxane-3,4,5-triol

C16H23N5O8 (413.1547)


   

methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate

methyl 3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoate

C21H19NO8 (413.1111)


   

[(2r,3s,4s,5r,6s)-6-[(1r)-1-cyano-1-methylpropoxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-6-[(1r)-1-cyano-1-methylpropoxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

[(2r,3s,4s,5r,6r)-6-{[(1r,2s)-1-cyano-1-methylpropan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6r)-6-{[(1r,2s)-1-cyano-1-methylpropan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C18H23NO10 (413.1322)


   

(1's,2s,9r,9as,12's)-15'-hydroxy-2-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

(1's,2s,9r,9as,12's)-15'-hydroxy-2-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

C23H19N5O3 (413.1488)


   

(3r)-6,7-dimethoxy-3-[(5r)-4-methoxy-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3h-2-benzofuran-1-one

(3r)-6,7-dimethoxy-3-[(5r)-4-methoxy-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3h-2-benzofuran-1-one

C22H23NO7 (413.1474)


   

(s)-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8r)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

(s)-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}[(1s,3s,4s,5r,8r)-2,4,5,8-tetrahydroxy-7-oxa-2-azabicyclo[3.2.1]octan-3-yl]acetic acid

C17H23N3O9 (413.1434)


   

2-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)-4-methoxyoxane-3,5-diol

2-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)-4-methoxyoxane-3,5-diol

C16H23N5O8 (413.1547)


   

(1s,13s,15s)-6-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-6-bromo-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H24BrN3O (413.1103)


   

7,8,21-trimethoxy-11-methyl-17,19-dioxa-11-azatetracyclo[12.7.0.0⁴,⁹.0¹⁶,²⁰]henicosa-1(21),4,6,8,14,16(20)-hexaene-2,3-dione

7,8,21-trimethoxy-11-methyl-17,19-dioxa-11-azatetracyclo[12.7.0.0⁴,⁹.0¹⁶,²⁰]henicosa-1(21),4,6,8,14,16(20)-hexaene-2,3-dione

C22H23NO7 (413.1474)


   

(1's,2s,9r,9as)-15'-hydroxy-2-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

(1's,2s,9r,9as)-15'-hydroxy-2-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

C23H19N5O3 (413.1488)


   

(1'r,9r,9as,12'r)-15'-hydroxy-12'-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

(1'r,9r,9as,12'r)-15'-hydroxy-12'-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

C23H19N5O3 (413.1488)


   

lycogalic ethyl ester

lycogalic ethyl ester

C24H19N3O4 (413.1375)


   

15'-hydroxy-12'-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

15'-hydroxy-12'-methyl-2,9a-dihydro-1h-2',10',16'-triazaspiro[imidazo[1,2-a]indole-9,13'-tetracyclo[10.2.2.0²,¹¹.0⁴,⁹]hexadecane]-4',6',8',10',15'-pentaene-3,3'-dione

C23H19N5O3 (413.1488)


   

(3e)-3-({6-[2-(dimethylamino)ethyl]-4-hydroxy-2h-1,3-benzodioxol-5-yl}methylidene)-6,7-dimethoxy-2-benzofuran-1-one

(3e)-3-({6-[2-(dimethylamino)ethyl]-4-hydroxy-2h-1,3-benzodioxol-5-yl}methylidene)-6,7-dimethoxy-2-benzofuran-1-one

C22H23NO7 (413.1474)


   

(2s,3r,4s,5r,6r)-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)-4-methoxyoxane-3,5-diol

(2s,3r,4s,5r,6r)-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)-4-methoxyoxane-3,5-diol

C16H23N5O8 (413.1547)